Improved bowel function may alleviate referred back discomfort
Organizations focused on diabetes management emphasize the importance of screening patient history before initiating therapy
On one hand, exenatide is a prototypical GLP-1RA known for its potent effects on weight reduction and lowering LFC, instilling confidence in its use for MASLD
Peptide medications, like most GLP-1 drugs, are especially challenging to deliver through the skins barrier because of their large molecular size
1 Originally developed to support blood sugar in type 2 diabetes, they've since become widely used for weight management, thanks to their ability to curb appetite, increase feelings of fullness, and support significant weight loss
The press release noted that no weight-loss plateau was observed through 40 weeks [8]